Cypherpunk’s $46M Zcash Markup Turns a $4.7M Operating Loss Into $39.4M of Net Income
Cypherpunk Technologies reported a net income of $39.4 million for the second quarter, largely due to a $46 million unrealized gain from its Zcash holdings. Excluding this accounting entry, the company incurred an operating loss of $4.7 million. The company's biotechnology subsidiary, Leap Therapeutics, is also seeking resources for its sirexatamab drug program.
EGamers.io
Original source
This article was reported and published by EGamers.io. feed.gg links to it as part of a story cluster — full text, images and rights remain with the publisher.